HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lefebvre, P. Articles by Cohen, I. Search for Related Content PubMed PubMed Citation Articles by Lefebvre, P. Articles by Cohen, I.

In Vitro Production of Megakaryocytes from PIXY321 versus GM-CSF-Mobilized Peripheral Blood Progenitor Cells

^a Department of Cell and Molecular Biology,
^b Department of Medicine,
^c Department of Preventive Medicine,
^d Department of Pathology and the Robert H. Lurie Cancer Center, Northwestern University Medical School, Chicago, Illinois, USA

Key Words. Megakaryocytes • PIXY321 • GM-CSF • Thrombopoietin • Cyclophosphamide • Peripheral blood progenitor cells

Dr. Isaac Cohen, Northwestern University, RIC 1407, 345 East Superior Street, Chicago, IL 60611, USA.

The generation of megakaryocytes (MK) from cultured peripheral blood progenitor cells (PBSC), harvested via apheresis, from 18 female breast cancer patients treated with either PIXY321 or GM-CSF was compared. Nonadherent mononuclear cells (MNC) were cultured in liquid suspension with 50 U/ml thrombopoietin (TPO) and 2.5% autologous heparinized plasma for 12 days. Flow cytometric analysis was used to measure the percentage of CD34⁺ on day 1 and CD41⁺ cells on day 12. The frequency of CD34⁺ cells was greater in GM-CSF-mobilized samples than in PIXY321-mobilized samples, and MK/MNC yields correlated directly with the number of CD34⁺ cells seeded. PIXY321-mobilized samples produced more MKs per CD34⁺ cell than GM-CSF-mobilized samples. Overall, there was no significant difference in the MK/MNC yield between PIXY321- and GM-CSF-mobilized samples. Cyclophosphamide (CY) increased the frequency of CD34⁺ cells and the corresponding MK/MNC yield for both cytokines, but had no effect on the MK/CD34⁺ yield. Compared to GM-CSF, PIXY321 mobilization resulted in increased CD34⁺ cell commitment to the MK lineage.

This article has been cited by other articles:

				F. Jiang, Y. Jia, and I. Cohen Fibronectin- and protein kinase C-mediated activation of ERK/MAPK are essential for proplateletlike formation Blood, May 15, 2002; 99(10): 3579 - 3584. [Abstract] [Full Text] [PDF]

				J. C.L. Schuh and P. J. Morrissey Development of a Recombinant Growth Factor and Fusion Protein: Lessons from GM-CSF Toxicol Pathol, January 1, 1999; 27(1): 72 - 77. [Abstract] [PDF]